MARSHALL WACE, LLP

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1318757 LONDON, X0

Position in ARQT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$11,716,826

-$45,575,863 QoQ

Shares Held

446,866

-81.6% QoQ

Ownership

0.356%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#46

of 271 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. ARQT ranks #64 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,716,826	446,866	-81.6%	Shares	Other	2026-08-13
2026-03-31	$57,292,689	2,431,778	+435.4%	Shares	Other	2026-05-15
2025-12-31	$13,190,925	454,233	+2382.1%	Shares	Other	2026-02-13
2025-09-30	$344,955	18,300	-68.4%	Shares	Other	2025-11-13
2025-03-31	$905,681	57,908	-39.1%	Shares	Other	2025-05-15
2023-12-31	$306,885	95,011	-95.9%	Shares	Other	2024-02-14
2023-09-30	$12,271,818	2,311,077	-0.3%	Shares	Other	2023-11-14
2023-06-30	$22,086,165	2,317,541	+0.5%	Shares	Other	2023-08-14
2023-03-31	$25,358,696	2,305,336	+1273.7%	Shares	Other	2023-05-15
2022-09-30	$3,206,963	167,816	+1008.6%	Shares	Other	2022-11-14
2021-06-30	$413,116	15,138	-91.1%	Shares	Sole	2021-08-13
2021-03-31	$4,903,258	169,487	+114.6%	Shares	Other	2021-05-17
2020-12-31	$2,221,510	78,973	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.